LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory (Beta)
US
New Jersey NJ
Legislatures
2022-2023 Regular Session
Senate
Bills
S3668
NJ
New Jersey Senate Bill S3668
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Meeting Calendar
New Jersey 2022-2023 Regular Session
New Jersey Senate Bill S3668
Introduced
2/28/23
Refer
2/28/23
Caption
Establishes tianeptine as Schedule II controlled dangerous substance.
Latest S3668 Activity
Companion Bills
No companion bills found.
Similar Bills
NJ S729
Establishes tianeptine as Schedule II controlled dangerous substance.
NJ A4814
Establishes tianeptine as Schedule II controlled dangerous substance.
MS HB4
Tianeptine; include in Schedule I controlled substance list.
MS SB2345
Tianeptine; classify as a Schedule I substance.
MS HB791
Tianeptine; add to Schedule II list of controlled substances.
MS HB662
Tianeptine; add to Schedule II list of controlled substances.
MI HB4913
Crimes: controlled substances; sale, distribution, or possession of xylazine; prohibit. Amends sec. 7214 of 1978 PA 368 (MCL 333.7214).
DE HB21
An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.